India’s first COVID-19 mRNA vaccine in final trials, says Dr VK Paul

India’s first messenger RNA (mRNA) Covid19 vaccine developed by Pune-based Gennova Biopharmaceuticals is currently undergoing final clinical trials, NITI Ayog‘s Member, Health, Dr VK Paulsaid Thursday.

Briefing the media, he said they hope to be able to use this vaccine soon.

“We need an mRNA platform because it has shown that vaccines developed on this platform, at least for Covid-19, have been effective around the world,” Paul said, adding that beyond Covid, this platform will continue to be important as an option going forward for other diseases as well for which vaccines have been elusive. He called it a great development.

Indian Council of Medical Research Director General Dr Balram Bhargava said this is another vaccine that really establishes that India is on its way to becoming a vaccine superpower.

“Because a large part of the population is vaccinated, we are not seeing the disastrous third surge of Covid in terms of hospitalizations and mortality,” he said.

About the ongoing pandemic situation, Dr. Paul said that the world has learned a lot about the pandemic and the virus, but they don’t know everything.

The world must stand together to fight this virus and must continue to use the tools that are available to us, he added.

“Some states including Kerala, Mizoram and Himachal Pradesh are still reporting large numbers of cases. We cannot let our guard down,” he said.

Online travel booking portal Cleartrip to increase its workforce by 400 by the end of this year

RBI proposes to increase limit of e-RUPI vouchers to ₹1 lakh

Comments are closed.